1.Kenya AIDS indicator survey (KAIS). 2012.
2.statistics KNBO. Kenya Demographic And Heath Survey 2008-2009. 2010.
5.Odhiambo JA, Borgdorff MW, Kiambih FM, et al. Tuberculosis and the HIV epidemic: increasing
annual risk of tuberculous infection in Kenya, 1986-1996. Am J Public Health. Jul 1999;89(7):1078-1082.
6.Kwamanga D, Chakaya J, Sitienei J, Kalisvaart N, L'Herminez R, van der Werf MJ. Tuberculosis
transmission in Kenya: results of the third National Tuberculin Survey. Int J Tuberc Lung Dis. Jun;14(6):695-700.
7.Bosman MC, Swai OB, Kwamanga DO, Agwanda R, Idukitta G, Misljenovic O. National tuberculin
survey of Kenya, 1986-1990. Int J Tuberc Lung Dis. Apr 1998;2(4):272-280.
8.Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention
of tuberculosis. Meta-analysis of the published literature. Jama. Mar 2 1994;271(9):698-702.
9.Mahomed H, Hawkridge T, Verver S, et al. Predictive factors for latent tuberculosis
infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis. Mar;15(3):331-336.
10.Odhiambo FO, Laserson KF, Sewe M, et al. Profile: the KEMRI/CDC Health and Demographic
Surveillance System--Western Kenya. Int J Epidemiol. Aug;41(4):977-987.
11.Nduba V, Hoog AH, Mitchell E, Onyango P, Laserson K, Borgdorff M. Prevalence of tuberculosis
in adolescents, western Kenya: implications for control programs. Int J Infect Dis. Jun 2015;35:11-17.
13.Rieder HL. Methodological issues in the estimation of the tuberculosis problem from
tuberculin surveys. Tuber Lung Dis. Apr 1995;76(2):114-121.
14.Adetifa IM, Muhammad AK, Jeffries D, et al. A Tuberculin Skin Test Survey and the
Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children. PLoS One.10(10):e0139354.
15.Dodd PJ, Looker C, Plumb ID, et al. Age- and Sex-Specific Social Contact Patterns
and Incidence of Mycobacterium tuberculosis Infection. Am J Epidemiol. Jan 15;183(2):156-166.
16.Sutherland I, Fayers PM. The association of the risk of tuberculous infection with
age. Bull Int Union Tuberc. 1975;50(1):70-81.
17.Nagelkerke N, Heisterkamp S, Borgdorff M, Broekmans J, Van Houwelingen H. Semi-parametric
estimation of age-time specific infection incidence from serial prevalence data. Stat Med. Feb 15 1999;18(3):307-320.
18.Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection
in children. Lancet Infect Dis. Mar 2019;19(3):e96-e108.
19.Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J. Jan 2005;25(1):181-185.
20.Fine PE, Ponnighaus JM, Maine N. The distribution and implications of BCG scars in
northern Malawi. Bull World Health Organ. 1989;67(1):35-42.
21.Chapman HJ, Lauzardo M. Advances in diagnosis and treatment of latent tuberculosis
infection. J Am Board Fam Med. Sep-Oct;27(5):704-712.
22.Andrews JR, Hatherill M, Mahomed H, et al. The dynamics of QuantiFERON-TB gold in-tube
conversion and reversion in a cohort of South African adolescents. Am J Respir Crit Care Med. Mar 1 2015;191(5):584-591.
23.Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what
is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. Nov 2006;10(11):1192-1204.
24.Hawn TR, Day TA, Scriba TJ, et al. Tuberculosis vaccines and prevention of infection.
Microbiol Mol Biol Rev. Dec 2014;78(4):650-671.
25.Marais BJ, Donald PR, Gie RP, Schaaf HS, Beyers N. Diversity of disease in childhood
pulmonary tuberculosis. Ann Trop Paediatr. Jun 2005;25(2):79-86.
26.Nduba V, Van't Hoog AH, Mitchell EMH, Borgdorff M, Laserson KF. Incidence of Active
Tuberculosis and Cohort Retention Among Adolescents in Western Kenya. Pediatr Infect Dis J. Jan 2018;37(1):10-15.